Furthermore, in a DSS‐induced colitis mouse model, UMSC treatment decreased the proportion of Th1 and Th17 cells and down‐regulated the expression of inflammatory cytokines, including IFN‐γ, IL‐1β, IL‐6, IL‐17, as well as TNF‐α at the mRNA levels. The gene discussed is IL17A; the disease is colitis.